Vandecandelaere A, Martin S R, Engelborghs Y
Laboratory of Chemical Biological Dynamics, Katholieke Universiteit te Leuven, Celestijnenlaan 200D, B-3001, Leuven, Belgium.
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):189-96. doi: 10.1042/bj3230189.
The effects of free drug and tubulin-drug complexes on steady-state GTP/GDP-associated microtubules and on equilibrium guanosine 5'[beta,gamma-imido]triphosphate-associated microtubules are compared. The addition of colchicine or the tubulin-colchicine complex (TuCol) to steady-state microtubules induces microtubule disassembly. Only limited disassembly of equilibrium microtubules is observed under similar conditions. Addition of colchicine or the bifunctional colchicine analogue 2-methoxy-5-(2'3',4'-trimethoxyphenyl)tropone to preassembled steady-state or equilibrium microtubules does induce disassembly, but establishment of the new steady state or equilibrium is very slow. These observations are related to the fact that TuCol readily adds to the microtubule end, but is only incorporated into the lattice with difficulty. As a result, microtubule growth is effectively inhibited and the critical concentration is significantly increased. Nevertheless, drug-induced disassembly can be extremely slow, because the frequency of addition reactions increases as the concentration of soluble dimers increases. The efficiency of incorporation of TuCol decreases as it concentration increases. The work further confirms the existence of colchicine-binding sites with low affinity (association constant KMT approximately 3 x 10(2) M-1) along the microtubule lattice. This value suggests that part of the colchicine-binding site on tubulin remains available in the polymer. The interaction of colchicine with these sites has no appreciable effect on microtubule dynamics. These observations are reproduced and rationalized by the model described elsewhere [Vandecandelaere, Martin, Bayley and Schilstra (1994) Biochemistry 33, 2792-2801], and the possibility that there are co-operative effects in the inhibition is considered.
比较了游离药物和微管蛋白 - 药物复合物对稳态GTP/GDP相关微管以及对平衡鸟苷5'-[β,γ-亚氨基]三磷酸相关微管的影响。向稳态微管中添加秋水仙碱或微管蛋白 - 秋水仙碱复合物(TuCol)会诱导微管解聚。在相似条件下,仅观察到平衡微管有限的解聚。向预先组装好的稳态或平衡微管中添加秋水仙碱或双功能秋水仙碱类似物2 - 甲氧基 - 5 -(2',3',4'-三甲氧基苯基)色酮确实会诱导解聚,但新稳态或平衡的建立非常缓慢。这些观察结果与以下事实相关:TuCol很容易添加到微管末端,但很难掺入晶格中。结果,微管生长受到有效抑制,临界浓度显著增加。然而,药物诱导的解聚可能极其缓慢,因为随着可溶性二聚体浓度的增加,添加反应的频率会增加。TuCol的掺入效率随着其浓度的增加而降低。这项工作进一步证实了沿着微管晶格存在低亲和力的秋水仙碱结合位点(缔合常数KMT约为3×10² M⁻¹)。该值表明微管蛋白上的部分秋水仙碱结合位点在聚合物中仍然可用。秋水仙碱与这些位点的相互作用对微管动力学没有明显影响。这些观察结果由其他地方描述的模型[Vandecandelaere, Martin, Bayley和Schilstra (1994) Biochemistry 33, 2792 - 2801]重现并合理化,并且考虑了抑制作用中存在协同效应的可能性。